What is Kalogon?
Kalogon specializes in the development and distribution of high-performance, medically-validated seating solutions designed to address the critical needs of wheelchair users, pilots, and professional drivers. Through its flagship product lines—including Orbiter Med, Orbiter, Bondar, and Booster—the company integrates sophisticated technology to provide dynamic, customized support. By focusing on seated health and pressure management, Kalogon has established a unique market position, bridging the gap between clinical necessity and consumer-grade comfort. The company's commitment to research and strategic partnerships with industry leaders positions it as a transformative force in the global seating market, effectively redefining standards for long-term seated health and ergonomic performance.
How much funding has Kalogon raised?
Kalogon has raised a total of $13.2M across 3 funding rounds:
Angel/Seed
$4.5M
Unspecified
$5.8M
Stock/Share Issuance
$2.9M
Angel/Seed (2024): $4.5M with participation from M7, Sawmill Angels, DeepWork Capital, venVelo, and Seedfundersorlando
Unspecified (2026): $5.8M led by Florida Opportunity Fund, Seedfunders, Castellan Group, DeepWork Capital, Black Opal Ventures, venVelo, and Enable Ventures
Stock/Share Issuance (2026): $2.9M, investors not publicly disclosed
Key Investors in Kalogon
DeepWork Capital
DeepWork Capital is a Florida-based venture firm that provides committed capital to growth-oriented early-stage companies within the technology and life science sectors.
venVelo
venVelo is a prominent early-stage venture fund that supports innovative startups through capital investment, mentorship, and deep integration into the Central Florida entrepreneurial ecosystem.
Seedfundersorlando
Seedfundersorlando is an organization comprised of experienced entrepreneurs who provide early-stage funding and operational expertise to foster innovation in the Central Florida economy.
What's next for Kalogon?
With the infusion of $2.9M, Kalogon is well-positioned to accelerate its research and development initiatives and expand its commercial footprint. The company's strategic roadmap likely involves scaling its manufacturing capabilities to meet increasing demand across the healthcare and transportation sectors. Furthermore, the continued support from institutional backers suggests a focus on deepening its intellectual property portfolio and exploring new applications for its pressure-management technology. As Kalogon matures, the emphasis will shift toward optimizing supply chain efficiencies and strengthening its presence in both domestic and international markets, ensuring that its innovative seating solutions become the standard for users requiring long-term, health-conscious support.
See full Kalogon company page
